Gregory Norden insider trades
Open-market stock purchases and sales by Gregory Norden, Director at Praxis Precision Medicines, Inc, from SEC Form 4 filings since Jan 20, 2011.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +203%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 10, 2026 | PRAX Praxis Precision Medicines, Inc | Bought (not open market) | — |
| Jun 10, 2026 | PRAX Praxis Precision Medicines, Inc | Bought (not open market) | — |
| Jun 5, 2026 | RPRX Royalty Pharma plc | Bought (not open market) | — |
| May 14, 2026 | RPRX Royalty Pharma plc | Sold | $161K |
| Mar 9, 2026 | ZTS Zoetis Inc | Sold (not open market) | — |
| Feb 19, 2026 | ZTS Zoetis Inc | Bought (not open market) | — |
| Feb 19, 2026 | ZTS Zoetis Inc | Sold (not open market) | $51.7K |
| Feb 19, 2026 | ZTS Zoetis Inc | Bought (not open market) | — |
| Feb 18, 2026 | ZTS Zoetis Inc | Bought (not open market) | — |
Companies traded
- PRAX Praxis Precision Medicines, Inc: other filings, last Jun 10, 2026
- RPRX Royalty Pharma plc: 2 sales, last Jun 5, 2026
- ZTS Zoetis Inc: 1 buy, 1 sale, last Mar 9, 2026
- NSTG NanoString Technologies Inc: 1 buy, 3 sales, last May 6, 2024
- ETTX Entasis Therapeutics Holdings Inc: other filings, last Jun 19, 2019
- KVA/KVB K-V Pharmaceutical Co: other filings, last Oct 10, 2013
- HGSI Human Genome Sciences Inc: 1 buy, last Jul 30, 2012